Perspective Therapeutics (CATX) Operating Margin (2010 - 2023)
Perspective Therapeutics recorded quarterly Operating Margin of 238.19% in Q4 2023, up 153.38% quarter-over-quarter from 446.22% in Q3 2023.
Perspective Therapeutics' Operating Margin history runs 14 years deep, the most recent figure standing at 238.19% for Q4 2023.
- In Q4 2023, Operating Margin changed N/A year-over-year to 238.19%; the TTM figure through Dec 2023 stood at 6678.79% (changed N/A YoY), while the FY2023 annual figure was 2855.02%, changed N/A from the prior year.
- Operating Margin came in at 238.19% for Q4 2023 at Perspective Therapeutics, up from 446.22% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 238.19% in Q4 2023 to a low of 650.27% in Q2 2023.
- A 5-year average of 117.36% and a median of 52.17% in 2020 frame the typical range for Operating Margin.
- Across the five-year window, Operating Margin soared 10184 bps in 2021 and plunged 56619 bps in 2023, its largest moves.
- Perspective Therapeutics' Operating Margin stood at 40.93% in 2019, then advanced by 10 bps to 37.01% in 2020, then tumbled by 57 bps to 58.06% in 2021, then tumbled by 322 bps to 245.08% in 2022, then jumped by 197 bps to 238.19% in 2023.
- According to Business Quant data, Operating Margin over the past three periods registered 238.19%, 446.22%, and 650.27% for Q4 2023, Q3 2023, and Q2 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.17% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 238.19% |
| Sep 30, 2023 | -446.22% |
| Jun 30, 2023 | -650.27% |
| Mar 31, 2023 | -533.39% |
| Sep 30, 2022 | -245.08% |
| Jun 30, 2022 | -84.07% |
| Mar 31, 2022 | -47.29% |
| Dec 31, 2021 | -58.06% |
| Sep 30, 2021 | -88.69% |
| Jun 30, 2021 | 49.67% |
| Mar 31, 2021 | -29.46% |
| Dec 31, 2020 | -37.01% |
| Sep 30, 2020 | -29.95% |
| Jun 30, 2020 | -52.17% |
| Mar 31, 2020 | -19.03% |
| Dec 31, 2019 | -40.93% |
| Sep 30, 2019 | -36.11% |
| Jun 30, 2019 | -59.46% |
| Mar 31, 2019 | -60.45% |
| Dec 31, 2018 | -75.05% |
| Sep 30, 2018 | -97.18% |
| Jun 30, 2018 | -147.85% |
| Mar 31, 2018 | -85.12% |
| Dec 31, 2017 | -95.57% |
| Sep 30, 2017 | -128.16% |
| Jun 30, 2017 | -136.06% |
| Mar 31, 2017 | -108.35% |
| Dec 31, 2016 | -143.87% |
| Sep 30, 2016 | -145.70% |
| Jun 30, 2016 | -111.96% |
| Mar 31, 2016 | -110.77% |
| Dec 31, 2015 | -118.59% |
| Sep 30, 2015 | -86.52% |
| Jun 30, 2015 | -82.38% |
| Mar 31, 2015 | -90.75% |
| Dec 31, 2014 | -95.75% |
| Sep 30, 2014 | -111.42% |
| Jun 30, 2014 | -139.05% |
| Mar 31, 2014 | -87.19% |
| Dec 31, 2013 | -96.22% |
| Sep 30, 2013 | -117.58% |
| Jun 30, 2013 | -82.19% |
| Mar 31, 2013 | -65.85% |
| Dec 31, 2012 | -112.71% |
| Sep 30, 2012 | -106.30% |
| Jun 30, 2012 | -71.72% |
| Mar 31, 2012 | -57.91% |
| Dec 31, 2011 | -64.46% |
| Sep 30, 2011 | -90.84% |
| Jun 30, 2011 | -61.01% |
| Mar 31, 2011 | -49.16% |
| Dec 31, 2010 | -50.98% |
| Sep 30, 2010 | -65.44% |